Killing Pancreatic Cancer with T Cells that Turbocharge ThemselvesNovel Immunotherapy Pumps Out Cancer-Killing Cytokines Only Inside the Tumor
Breast Cancer Risk Calculator Can Assess Risk of Advanced Breast CancerUpcoming Conference to Focus on Breast Density and Prediction of Advanced and Interval Breast Cancer Risk
UCSF and I-SPY 2 Breast Cancer Researchers Develop Newly Redefined Breast Cancer Response SubtypesResearch scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients.
“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy CellsNew approach by UCSF researchers analyzes how well different re-engineered T cells work against cancer.
Drug Turns Cancer Gene Into "Eat Me" Flag for Immune SystemUCSF-led study shows promising pre-clinical results in killing cancer cells resistant to current KRAS-targeted treatments.
How AI Found the Words to Kill Cancer CellsPredictive model allows researchers to encode commands for cells to carry out.
Enhancing Care for Thoracic Oncology Surgery PatientsBuilding on a decades-long reputation for innovation in thoracic surgery, UC San Francisco’s Thoracic Surgery and Oncology Clinic has improved the overall experience for patients undergoing lung and esophageal cancer treatment while continuing to maintain strong outcomes.
UCSF Researchers Uncover New Pathway for Molecular Cancer Drug TherapiesIn a study published December 8, 2022 in Science, UCSF researchers Kevin Lou, an MD-PhD student, Luke Gilbert, PhD, and Kevan Shokat, PhD, reveal the discovery of a cellular uptake pathway important for larger molecules.
Rethinking How Cancer Cells Evade Targeted TherapyGlioblastomas (GBMs) are incurable brain tumors with a prognosis of about one-and-a half years on average. They are highly resistant to treatment and have defied all attempts at precision therapy.
International Hematologic Conference Features UCSF Health ExpertsHematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.
International Conference Features UCSF Breast Cancer ExpertsBreast cancer experts from UCSF Health presented new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference.
UCSF Cancer Specialist Recognized with Luminary Award for Gastrointestinal CancersAlan P. Venook, MD, a renowned expert in colorectal and liver cancers, has been announced as one of the winners of the 2022 Luminary Awards in Gastrointestinal (GI) Cancers.
Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic CancerTumor Immune Microenvironments May Provide Clues to Future Therapies
Screening and Removal of Precancerous Lesions Prevents Anal CancerNational study led by UCSF is first to show effectiveness of simple strategies to reduce risk of often silent cancer.
UCSF Surgeons Perform First Pure Robotic Whipple Surgery in the Bay AreaGastrointestinal surgeons at UC San Francisco have performed the first pure robotically assisted Whipple surgery in San Francisco.
Genomic Sequencing Is Changing Diagnosis, Treatment for Patients with Brain CancerPatients diagnosed with a type of brain tumor survived for longer when they were treated aggressively with surgery, radiation and chemotherapy.
Abortion Ban May Increase Risk of Death for Pregnant Women with CancerThe repercussions of overturning Roe v. Wade – and the failure of the Supreme Court to provide any guidance on exceptions related to the life and health of the mother – are potentially catastrophic for a subset of women who face a life-threating diagnosis of pregnancy associated cancers (PAC).
Brachytherapy Improves Outcomes for Cervical Cancer PatientsPatients with locally advanced cervical cancer who receive chemoradiation therapy and brachytherapy and complete treatment within eight weeks have a superior overall survival rate compared to those who don’t receive this treatment, according to a UCSF study.
Renal Cell Carcinoma Research Sheds New Light on Advanced DiseaseIn a recent study, UCSF researchers found that renal cell carcinoma (RCC)with venous tumor thrombus(VTT) does not always signify metastatic disease with poor prognosis. These findings provide insight into the development of advanced RCC and may help to better inform surveillance regimens and treatment decisions and, ultimately, improve clinical outcomes.
Novel Hyperglycemia Management Protocol for Patients Undergoing Cancer TreatmentAn innovative hyperglycemia management protocol for patients receiving cancer therapy is provided through an urgent-care site within the UCSF Infusion Center, and can be replicated at other centers. The protocol ensures that patients promptly get the necessary treatment for acute hyperglycemia that can occur during cancer therapy.
UCSF Prostate Cancer Specialist Inducted into Annual Class of “Giants of Cancer Care”Eric Small, MD, has been announced as one of the winners of the 10th annual Giants of Cancer Care® awards.
Renowned Expert to Lead UCSF’s Hematology and Oncology DivisionKrishna Komanduri, MD, an international leader in hematology-oncology, transplantation and cellular immunotherapy, is the new chief of UCSF’s Division of Hematology and Oncology.
Advancing Precision Medicine for Neuro-Oncology Patients: Q&A with David Solomon, MD, PhDUC San Francisco neuropathologist and molecular neuro-oncologist David Solomon, MD, PhD has reached a unique and impressive milestone: the publication of his team's 50th neuro-oncology research study stemming from the UCSF500 Cancer Gene Panel, a molecular diagnostic test that identifies genetic changes in the DNA of a patient's cancer.
UCSF Deploys Innovative Data System to Integrate Research and CareUC San Francisco (UCSF), in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA) has developed the OneSource system to seamlessly integrate clinical care and research data.